Department of Geriatric Medicine General Medicine Renal Medicine Metabolic Bone Disorder Clinic, Western Health, Melbourne, Victoria, Australia.
Intern Med J. 2011 Nov;41(11):761-8. doi: 10.1111/j.1445-5994.2011.02590.x.
Both chronic kidney disease (CKD) and end-stage renal disease are strongly age related. Although the morbidity and mortality of CKD have significantly improved in recent years because of a greater understanding of its pathophysiology and evidence-based approach to management, the application of this evidence to the elderly CKD patients is often fraught with difficulty. This is because, besides age, the clinical and biological variables that are widely prevalent in the elderly, such as multiple co-morbidities, functional impairments and polypharmacy, and quality of life and functional outcome measures, which are pertinent to this age group, have generally not been incorporated into the available evidence. This paper reviews the current evidence with a view to providing a framework for diagnosing and managing CKD in the elderly. Special references are made to age-related physiological changes in the renal system, assessment of renal function, and management of metabolic complications and end-stage renal disease.
慢性肾脏病(CKD)和终末期肾病都与年龄密切相关。尽管近年来由于对其病理生理学的更深入了解以及循证管理方法的应用,CKD 的发病率和死亡率已显著改善,但将这些证据应用于老年 CKD 患者时往往困难重重。这是因为,除了年龄以外,在老年人中广泛存在的临床和生物学变量,如多种合并症、功能障碍和多种药物治疗,以及与该年龄组相关的生活质量和功能结果测量,通常并未纳入现有证据中。本文综述了目前的证据,以期为老年 CKD 的诊断和治疗提供框架。本文特别提到了与年龄相关的肾脏系统生理变化、肾功能评估以及代谢并发症和终末期肾病的管理。